Evaluation and Management of Intermediate and High-Risk Pulmonary Embolism.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31743047.
- Also identified by DOI 10.2214/AJR.19.21861.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> The evidence regarding pulmonary embolism treatment has greatly advanced over the past 10 years, particularly in patients with right ventricular dysfunction or hemodynamic instability. Treatment options include systemic anticoagulation, systemic thrombolysis, catheter-assisted thrombus removal (mechanical with or without catheter-directed thrombolysis), and surgical embolectomy. <b>CONCLUSION.</b> This article will review the data available for treatment options and summarize the evidence-based guidelines on treatment of intermediate- or high-risk pulmonary embolism.
Medical subject headings
- Pulmonary Embolism